New target for Health Dept: 1.49 lakh HPV vaccinations in 100 days, Pg6

Key Highlights:

• Delhi's Health Department has set an ambitious target to administer 1.49 lakh Human Papillomavirus (HPV) vaccinations to girls within 100 days.
• This renewed effort aims to accelerate coverage after the initial phase of the National HPV Vaccination Programme saw slower-than-anticipated progress in Delhi.
• The nationwide program, launched on February 28, targets approximately 1.15 crore 14-year-old girls annually across India.
• Cervical cancer, primarily caused by HPV, is the second most common cancer among women in India.

Detailed Insights:

• The initial slow vaccination rate in Delhi was attributed to school examinations and subsequent summer vacations.
• The Health Department is now collaborating closely with the Education Department, conducting virtual and in-person meetings with school officials.
• Medical professionals are actively visiting schools to raise awareness about HPV and the benefits of vaccination.
• An intensive communication campaign is being implemented to combat vaccine hesitancy through educational videos and testimonials.
• The National HPV Vaccination Programme offers free, single-dose vaccination for eligible 14-year-old girls at government health facilities.
• The program utilizes the U-WIN digital platform for efficient registration, appointment scheduling, and tracking of vaccinations.
• India contributes significantly to the global burden of cervical cancer, accounting for about 25% of worldwide deaths.
• The vaccine currently used in the national program is Gardasil-4, which protects against specific high-risk HPV types.
• India is also developing an indigenous quadrivalent HPV vaccine named Cervavac through the Serum Institute of India.
• The World Health Organization (WHO) aims for 90% of girls globally to be fully vaccinated against HPV by age 15 by 2030.

Key Concepts Involved:

• Human Papillomavirus (HPV): A common group of viruses, certain high-risk types of which are the primary cause of cervical and other cancers.
• Cervical Cancer: A type of cancer that develops in the cervix, almost exclusively caused by persistent infection with high-risk HPV.
• Vaccine Hesitancy: The reluctance or refusal to vaccinate despite the availability of vaccines, often influenced by misinformation or lack of trust.
• National HPV Vaccination Programme: A government initiative in India providing free HPV vaccination to adolescent girls to prevent cervical cancer.